In this activity, Congress Chair Dr. Morton Coleman and CLL Session Co-Chair Dr. Richard R. Furman discuss highlights of the second day of Lymphoma & Myeloma 2017: An International Congress on Hematologic Malignancies held in October. Topics of discussion were focused on best practices and emerging data regarding CLL management, including: the changing role of chemotherapy in CLL, best use of Bruton’s tyrosine kinase (BTK) inhibitors, and managing adverse events associated with newer CLL therapies.
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?specialty=Hematology
© 2017 Imedex, LLC.